What can be expected? A reasonable market cap.
CLVS, EXAS, ICPT, PUMA... reached multi $billion valuations before any product was approved.
There are countless biotechs in the $hundreds of millions valuations that have produced nothing.
INO is at $500M after 36 years of failure, never having completed even one phase 3 trial.
What is GTHP's market cap?